Gary Marks1, Unnati Patel, Michael J Stirratt, Michael J Mugavero, William C Mathews, Thomas P Giordano, Nicole Crepaz, Lytt I Gardner, Cynthia Grossman, Jessica Davila, Meg Sullivan, Charles E Rose, Christine OʼDaniels, Allan Rodriguez, Andrew J Wawrzyniak, Matthew R Golden, Shireesha Dhanireddy, Jacqueline Ellison, Mari-Lynn Drainoni, Lisa R Metsch, Edward R Cachay. 1. *Division of HIV/AIDS Prevention, Centers for Disease Control and Prevention, Atlanta, GA; †ICF International, Atlanta, GA; ‡Division of AIDS Research, National Institute of Mental Health, Bethesda, MD; §1917 HIV/AIDS Clinic and Department of Medicine, University of Alabama, Birmingham; ‖Department of Medicine, University of California, San Diego; ¶Department of Medicine, Baylor College of Medicine, and the Center for Innovations in Quality, Effectiveness and Safety, Michael E. DeBakey Veterans Affairs Medical Center, Houston, TX; #Department of Medicine, Boston University School of Medicine, Boston, MA; **Carter Consulting, Inc, Atlanta, GA; ††Division of Infectious Diseases, Miller School of Medicine, University of Miami, FL; ‡‡Psychiatry and Behavioral Sciences, University of Miami Miller School of Medicine, Miami, FL; §§Center for AIDS and STD and Public Health-Seattle and King County, University of Washington, Seattle, WA; ‖‖Department of Medicine, University of Washington, Seattle, WA; ¶¶School of Public Health, Boston University, Boston, MA; and ##Mailman School of Public Health, Columbia University, New York, NY.
Abstract
BACKGROUND: The HIV continuum of care paradigm uses a single viral load test per patient to estimate the prevalence of viral suppression. We compared this single-value approach with approaches that used multiple viral load tests to examine the stability of suppression. METHODS: The retrospective analysis included HIV patients who had at least 2 viral load tests during a 12-month observation period. We assessed the (1) percent with suppressed viral load (<200 copies/mL) based on a single test during observation, (2) percent with suppressed viral loads on all tests during observation, (3) percent who maintained viral suppression among patients whose first observed viral load was suppressed, and (4) change in viral suppression status comparing first with last measurement occasions. Prevalence ratios compared demographic and clinical subgroups. RESULTS: Of 10,942 patients, 78.5% had a suppressed viral load based on a single test, whereas 65.9% were virally suppressed on all tests during observation. Of patients whose first observed viral load was suppressed, 87.5% were suppressed on all subsequent tests in the next 12 months. More patients exhibited improving status (13.3% went from unsuppressed to suppressed) than worsening status (5.6% went from suppressed to unsuppressed). Stable suppression was less likely among women, younger patients, black patients, those recently diagnosed with HIV, and those who missed ≥1 scheduled clinic visits. CONCLUSIONS: Using single viral load measurements overestimated the percent of HIV patients with stable suppressed viral load by 16% (relative difference). Targeted clinical interventions are needed to increase the percent of patients with stable suppression.
BACKGROUND: The HIV continuum of care paradigm uses a single viral load test per patient to estimate the prevalence of viral suppression. We compared this single-value approach with approaches that used multiple viral load tests to examine the stability of suppression. METHODS: The retrospective analysis included HIVpatients who had at least 2 viral load tests during a 12-month observation period. We assessed the (1) percent with suppressed viral load (<200 copies/mL) based on a single test during observation, (2) percent with suppressed viral loads on all tests during observation, (3) percent who maintained viral suppression among patients whose first observed viral load was suppressed, and (4) change in viral suppression status comparing first with last measurement occasions. Prevalence ratios compared demographic and clinical subgroups. RESULTS: Of 10,942 patients, 78.5% had a suppressed viral load based on a single test, whereas 65.9% were virally suppressed on all tests during observation. Of patients whose first observed viral load was suppressed, 87.5% were suppressed on all subsequent tests in the next 12 months. More patients exhibited improving status (13.3% went from unsuppressed to suppressed) than worsening status (5.6% went from suppressed to unsuppressed). Stable suppression was less likely among women, younger patients, black patients, those recently diagnosed with HIV, and those who missed ≥1 scheduled clinic visits. CONCLUSIONS: Using single viral load measurements overestimated the percent of HIVpatients with stable suppressed viral load by 16% (relative difference). Targeted clinical interventions are needed to increase the percent of patients with stable suppression.
Authors: Michael J Mugavero; K Rivet Amico; Andrew O Westfall; Heidi M Crane; Anne Zinski; James H Willig; Julia C Dombrowski; Wynne E Norton; James L Raper; Mari M Kitahata; Michael S Saag Journal: J Acquir Immune Defic Syndr Date: 2012-01-01 Impact factor: 3.731
Authors: Baligh R Yehia; Benjamin French; John A Fleishman; Joshua P Metlay; Stephen A Berry; P Todd Korthuis; Allison L Agwu; Kelly A Gebo Journal: J Acquir Immune Defic Syndr Date: 2014-03-01 Impact factor: 3.731
Authors: Julia C Dombrowski; Mari M Kitahata; Stephen E Van Rompaey; Heidi M Crane; Michael J Mugavero; Joseph J Eron; Stephen L Boswell; Benigno Rodriguez; W Christopher Mathews; Jeffrey N Martin; Richard D Moore; Matthew R Golden Journal: J Acquir Immune Defic Syndr Date: 2013-07-01 Impact factor: 3.731
Authors: Lytt I Gardner; Gary Marks; Jason A Craw; Tracey E Wilson; Mari-Lynn Drainoni; Richard D Moore; Michael J Mugavero; Allan E Rodriguez; Lucy A Bradley-Springer; Susan Holman; Jeanne C Keruly; Meg Sullivan; Paul R Skolnik; Faye Malitz; Lisa R Metsch; James L Raper; Thomas P Giordano Journal: Clin Infect Dis Date: 2012-07-24 Impact factor: 9.079
Authors: Edward M Gardner; Margaret P McLees; John F Steiner; Carlos Del Rio; William J Burman Journal: Clin Infect Dis Date: 2011-03-15 Impact factor: 9.079
Authors: Chanelle J Howe; Sonia Napravnik; Stephen R Cole; Jay S Kaufman; Adaora A Adimora; Beth Elston; Joseph J Eron; Michael J Mugavero Journal: Am J Epidemiol Date: 2014-05-08 Impact factor: 4.897
Authors: Keri N Althoff; Kate Buchacz; H Irene Hall; Jinbing Zhang; David B Hanna; Peter Rebeiro; Stephen J Gange; Richard D Moore; Mari M Kitahata; Kelly A Gebo; Jeffrey Martin; Amy C Justice; Michael A Horberg; Robert S Hogg; Timothy R Sterling; Angela Cescon; Marina B Klein; Jennifer E Thorne; Heidi M Crane; Michael J Mugavero; Sonia Napravnik; Gregory D Kirk; Lisa P Jacobson; John T Brooks Journal: Ann Intern Med Date: 2012-09-04 Impact factor: 25.391
Authors: Heather Bradley; H Irene Hall; Richard J Wolitski; Michelle M Van Handel; Amy E Stone; Michael LaFlam; Jacek Skarbinski; Darrel H Higa; Joseph Prejean; Emma L Frazier; Roshni Patel; Ping Huang; Qian An; Ruiguang Song; Tian Tang; Linda A Valleroy Journal: MMWR Morb Mortal Wkly Rep Date: 2014-11-28 Impact factor: 17.586
Authors: Kate Buchacz; Carl Armon; Ellen Tedaldi; Frank J Palella; Richard M Novak; Douglas Ward; Rachel Hart; Marcus D Durham; John T Brooks Journal: AIDS Res Hum Retroviruses Date: 2018-02-13 Impact factor: 2.205
Authors: Tracey E Wilson; Emma Sophia Kay; Bulent Turan; Mallory O Johnson; Mirjam-Colette Kempf; Janet M Turan; Mardge H Cohen; Adaora A Adimora; Margaret Pereyra; Elizabeth T Golub; Lakshmi Goparaju; Lynn Murchison; Gina M Wingood; Lisa R Metsch Journal: Am J Prev Med Date: 2018-04-12 Impact factor: 5.043
Authors: Forrest Toegel; August F Holtyn; Sarah Pollock; Andrew M Rodewald; Jeannie-Marie Leoutsakos; Michael Fingerhood; Kenneth Silverman Journal: HIV Res Clin Pract Date: 2020-03-05
Authors: Kate Buchacz; Jennifer Farrior; Geetha Beauchamp; Laura McKinstry; Ann E Kurth; Barry S Zingman; Fred M Gordin; Deborah Donnell; Kenneth H Mayer; Wafaa M El-Sadr; Bernard Branson Journal: J Int Assoc Provid AIDS Care Date: 2016-10-05
Authors: Kathy K Byrd; John G Hou; Tim Bush; Ron Hazen; Heather Kirkham; Ambrose Delpino; Paul J Weidle; Michael D Shankle; Nasima M Camp; Sumihiro Suzuki; Patrick G Clay Journal: Clin Infect Dis Date: 2020-02-14 Impact factor: 9.079
Authors: Seth C Kalichman; Harold Katner; Lisa A Eaton; Ellen Banas; Marnie Hill; Moira O Kalichman Journal: Transl Behav Med Date: 2021-04-07 Impact factor: 3.046